PMID: 737098Dec 1, 1978Paper

Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension

British Heart Journal
J SzczeklikT Horzela


The effects of prostaglandin E1 on pulmonary circulation and left ventricular performance have been studied in 20 patients with mitral valve disease and pulmonary hypertension. Prostaglandin E1 was administered intravenously over a period of 30 minutes. The dose used was 0.01 microgram/kg per min during the first 15 minutes and 0.02 microgram/kg per min subsequently. The first dose led only to an insignificant fall in left ventricular end-diastolic pressure. Infusion of prostaglandin E1 in a dose of 0.02 microgram/kg per min resulted in a significant fall in the pulmonary arterial pressure (P less than 0.001), total pulmonary resistance (P less than 0.001), left ventricular end-diastolic pressure (P less than 0.001), and aortic pressure (P less than 0.01), and an increase in the pulmonary blood volume (P less than 0.01), cardiac index (P less than 0.01), and heart rate (P less than 0.05). No significant differences were noted in stroke volume index or left ventricular dP/dt at 50 mmHg after prostaglandin E1. These results indicate that exogenously administered prostaglandin E1 causes active vasodilatation of the pulmonary vascular bed and has no inotropic action on the cardiac muscle.


Nov 1, 1975·Proceedings of the Society for Experimental Biology and Medicine·P D JoinerA L Hyman
Nov 1, 1973·European Journal of Pharmacology·M C KossJ Nakano
Jan 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·P J KadowitzA L Hyman
Jan 1, 1969·Acta Physiologica Scandinavica·L A CarlsonL Orö
Mar 31, 1959·Acta Physiologica Scandinavica·S BERGSTROMJ SJOVALL
Aug 1, 1962·Circulation·L DONATOA COURNAND

❮ Previous
Next ❯


Jan 1, 1993·European Journal of Clinical Pharmacology·K AbeT Sakakibara
Jan 1, 1983·European Journal of Clinical Pharmacology·N NaeijeR Sergijsels
Aug 10, 2010·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Sheng-Dan JiangLi-Yang Dai
Mar 1, 2005·Surgical Neurology·Ryoichi ShibuyaHideki Yoshikawa
Aug 1, 1985·Journal of the American College of Cardiology·B HoitR Shabetai
Dec 1, 1990·Journal of Cardiothoracic Anesthesia·J L WhiteY D Kim
Feb 18, 2010·Cardiology in Review·Subramanyam N MurthyPhilip J Kadowitz
Sep 1, 1980·British Heart Journal·J SzczeklikR Nizankowski
Apr 1, 1981·British Heart Journal·D N GuadagniA H Maslowski
Sep 1, 1987·The American Review of Respiratory Disease·W A Long, L J Rubin
Mar 29, 2014·Molecular Medicine·Patrick Crosswhite, Zhongjie Sun
May 1, 1985·Chest·J I Kennedy, J D Fulmer
Feb 2, 2010·Pharmacology & Therapeutics·Paul JuraszDuncan J Stewart
Sep 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K AbeM Kakiuchi
Jul 1, 1981·Prostaglandins and Medicine·E EkiciS Ozme
Nov 1, 1993·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K AbeY Shimada
Aug 1, 1993·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K AbeI Yoshiya
May 2, 2012·European Journal of Pharmacology·Jon RiiseKurt A Krobert
Feb 18, 1982·The American Journal of Cardiology·B J CreveyS D Walker
Apr 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K AbeY Shimada
Sep 1, 1980·British Heart Journal·F CameriniA Salvi
Nov 1, 1988·Progress in Cardiovascular Diseases·S Rich

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.